Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice

Proceedings of the National Academy of Sciences of the United States of America

Volumn 95, Issue 25, 1998, Pages 15049-15054

  Heisler, Lora K ^a   Chu, Hung Ming ^a   Brennan, Thomas J ^a,c   Danao, Jean A ^a   Bajwa, Preetpaul ^a   Parsons, Loren H ^b   Tecott, Laurence H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c Deltagen Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; MESSENGER RNA; NEUROLEPTIC AGENT; SEROTONIN; SEROTONIN 1A RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; DEPRESSION; EMBRYO; FEMALE; GENE TARGETING; HYPOTHERMIA; IMMUNOHISTOCHEMISTRY; MALE; MAZE TEST; MOUSE; NONHUMAN; NORTHERN BLOTTING; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM;

ANIMALS; ANXIETY; BRAIN; DEPRESSION; GENE TARGETING; MALE; MICE; MICE, INBRED C57BL; MUTATION; RECEPTORS, SEROTONIN;

ANIMALIA;

EID: 0032410750     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.95.25.15049     Document Type: Article

References (39)

1. Bloom, F. E. & Kupfer, D. J. (1995) Psychopharmacology: The Fourth Generation of Progress (Raven, New York).
2. Hoyer, D., Clarke, D. E., Fozard, J. R., Hartig, P. R., Martin, G. R., Mylecharane, E. J., Saxena, P. R. & Humphrey, P. P. (1994) Pharmacol. Rev. 46, 157-203.
3. Barrett, J. E. & Vanover, K. E. (1993) Psychopharmacology 112, 1-12.
4. Artigas, F., Romero, L., de Montigny, C. & Blier, P. (1996) Trends Neurosci. 19, 378-383.
5. Sotelo, C., Cholley, B., El Mestikawy, S., Gozlan, H. & Hamon, M. (1990) Eur. J. Neurosci. 2, 1144-1154.
6. Sprouse, J. S. & Aghajanian, G. K. (1987) Synapse 1, 3-9.
7. Pompeiano, M., Palacios, I. & Mengod, G. (1992) J. Neurosci. ç. 12, 440-453.
8. Fletcher, A., Bill, D. J., Cliffe, I. A., Forster, E. A. & Reilly, Y. (1994) Br. J. Pharmacol. 112, 91P.
9. Dourish, C. T., Hutson, P. H. & Curzon, G. (1985) Psychopharmacology 86, 197-204.
10. Hjorth, S. (1985) J. Neural Transm. 61, 131-135.
11. Fletcher, A., Cliffe, I. A. & Dourish, C. T. (1993) Trends Pharmacol. Sci. 14, 441-448.
12. File, S. E., Gonzalez, L. E. & Andrews, N. (1996) J. Neurosci. 16, 4810-4815.
13. Forster, E. A., Cliffe, I. A., Bill, D. J., Dover, G. M., Jones, D., Reilly, Y. & Fletcher, A. (1995) Eur. J. Pharmacol. 281, 81-88.
14. Fletcher, A., Forster, E. A., Bill, D. J., Brown, G., Cliffe, I. A., Hartley, J. E., Jones, D. E., McLenachan, A., Stanhope, K. J., Critchley, D. J., et al. (1996) Behav. Brain Res. 337-353.
15. Qiu, M., Bulfone, A., Martinez, S., Meneses, J. J., Shimamura, K., Pedersen, R. A. & Rubenstein, J. L. (1995) Genes Dev. 9, 2523-2538.
16. Mansour, S. L., Thomas, K. R. & Capecchi, M. R. (1988) Nature (London) 336, 348-352.
17. Chomczynski, P. & Sacchi, N. (1987) Anal. Biochem. 162, 156-159.
18. Goodwin, G. M., De Souza, R. J. & Green, A. R. (1985) Neuropharmacology 24, 1187-1194.
19. Whitaker-Azmitia, P. (1991) Pharmacol. Rev. 43, 553-561.
20. Treit, D. & Fundytus, M. (1988) Pharmacol. Biochem. Behav. 31, 958-962.
21. Simon, P., Dupuis, R. & Costentin, J. (1994) Behav. Brain Res. 61, 59-64.
22. Shepherd, J. K., Grewal, S. S., Fletcher, A., Bill, D. J. & Dourish, C. T. (1994) Psychopharmacology 116, 56-64.
23. Belzung, C. & Le Pape, G. (1993) Physiol. Behav. 56, 623-628.
24. Cole, J. C. & Rodgers, R. J. (1994) Psychopharmacology 114, 288-296.
25. Remy, S. M., Schreiber, R., Dalmus, M. & De Vry, J. (1996) Psychopharmacology 125, 89-91.
26. Stanhope, K. J. & Dourish, C. T. (1996) Psychopharmacology 128, 293-303.
27. Cao, B. J. & Rodgers, R. J. (1997) Pharmacol. Biochem. Behav. 58, 593-603.
28. File, S. E. (1996) Pharmacol. Biochem. Behav. 54, 3-12.
29. Higgins, G. A., Bradbury, A. J., Jones, B. J. & Oakley, N. R. (1988) Neuropharmacology 27, 993-1001.
30. Sharp, F. R., Sagar, S. M. & Swanson, R. A. (1993) Crit. Rev. Neurobiol. 7, 205-228.
31. Andrews, N., Hogg, S., Gonzales, L. E. & File, S. E. (1994) Eur. J. Pharmacol. 264, 259-264.
32. De Vry, J. (1995) Psychopharmacology 121, 1-26.
33. Blier, P. & de Montigny, C. (1994) Trends Pharmacol. Sci. 15, 220-226.
34. Steru, L., Chermat, R., Thierry, B. & Simon, P. (1985) Psychopharmacology 85, 367-370.
35. Steru, L., Chermat, R., Thierry, B., Mico, J. A., Lenegre, A., Steru, M. & Simon, P. (1987) Prog. Neuropsychpharmacol. Biol. Psychiatry 11, 659-671.
36. van der Heyden, J. A., Molewijk, E. & Olivier, B. (1987) Psychopharmacology 92, 127-130.
37. Blier, P., de Montigny, C. & Chaput, Y. (1987) J. Clin. Psychopharmacol. 7, 24S-35S.
38. Blier, P. & Bergeron, R. (1998) J. Clin. Psychiatry 59, Suppl. 5, 16-23; discussion 24-25.
39. Franklin, K. J. & Paxinos, G. (1997) The Mouse Brain in Stereotaxic Coordinates (Academic, San Diego).